FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

31,116 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 600 - 800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302Rhinosinusitisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303Nasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304Nasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305Nasal Polyposisactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306Suspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307Suspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308Suspected Nasal Neoplasmactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309Other sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310Other sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319Intranasal Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320Mast Cell Stabilizersactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321Ophthalmic Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215Sneezing as a findingactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216Sneezing as a Clinical Conditionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217Pruritus Unspecified or Other Locationactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218Pruritus Unspecified or Other Locationactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272Specific IgE Testing for Allergiesactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273Immunoglobulin G Testingactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274Total IgE Testingactive2017-03ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290Clinicians who perform allergy testingactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279Radiography of face, head or neckactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315Intranasal Corticosteroidsactive2017-03ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316Eustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317Eustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318Eustachian Tube Dysfunctionactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287Oral Second Generation and Less Sedating Antihistaminesactive2017-05ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266Leukotriene antagonistactive2017-03ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267Immunotherapy that is not Identified as Subcutaneousactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268Immunotherapyactive2017-03ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653Fidaxomicinactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657Clostridium difficile infectionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594Complete Blood Count (with Diff)active2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662Metronidazole Systemicactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663Vancomycin non injectableactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665Creatinineactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722Ileus due to infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723Ileus due to infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724Ileus due to infectionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725Vomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726Vomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727Vomiting potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728Toxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729Toxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730Toxic Megacolon in adultsactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731Abdominal Distensionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732Abdominal Distensionactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688Septic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689Septic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690Septic Shock due to C. Diffactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658Antiperistaltic agents to avoid in C. diffactive2019-04ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734Systemic Antimicrobial Medications not used for CDIactive2019-05ushl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659Recurrent Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660History of CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661Consult Infectious Diseaseactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691Abdominal Xrays for CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692CT of abdomen with contrast for fulminant CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693Surgical consult for CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694Fecal microbiota transplantationactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645Hospitalistactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697Positive result indicatoractive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698Clostridium Difficile Testactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646Body Temperatureactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647Body Temperatureactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648Diarrhea Potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649Diarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650Diarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651Leukocyte countactive2019-04ushl7loinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652Inpatient Settingactive2019-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1010.4Medication Clinical Drugactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1010.5Medication Clinical Brand specific Drugactive2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1010.6CVX Vaccines Administered Vaccine Setactive2025-04ushl7cvx
us.nlm.vsacR42.16.840.1.113762.1.4.1021.102Unknown or did not answeractive2021-10ushl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.103Other or unknown or refused to answeractive2021-11ushl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.12Low Molecular Weight Heparin for VTE prophylaxis ingredient specificactive2025-04ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1021.14Published test VSactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1021.24Birth Sexactive2024-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1021.46Device Magnetic resonance (MR) Safetyactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.47Device Latex Safetyactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.48Implantable Device Statusactive2024-06ushl7ncit
us.nlm.vsacR42.16.840.1.113762.1.4.1021.56Medical Reason Not Done SCTactive2019-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.119Phototherapyactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.120Phototherapyactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.121Phototherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.122Neonatal Jaundiceactive2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.123Neonatal Jaundiceactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.124Neonatal Jaundiceactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.125Maternal Drug Useactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.126Maternal Drug Useactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.127Maternal Drug Useactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.128Fetal Conditionsactive2025-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.129Fetal Conditionsactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.130Fetal Conditionsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.131Congenital Malformationsactive2025-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.132Congenital Malformationsactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.133Congenital Malformationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.134Social Indicationsactive2024-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.135Social Indicationsactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.136Social Indicationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.137Neonatal Severe Birth Traumaactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.138Neonatal Severe Birth Traumaactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.139Neonatal Severe Birth Traumaactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.140Neonatal Severe Hypoxia or Asphyxiaactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.141Neonatal Severe Hypoxia or Asphyxiaactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.142Neonatal Severe Hypoxia or Asphyxiaactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.143Neonatal Severe Shock and Resuscitationactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.144Neonatal Severe Shock and Resuscitationactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.145Neonatal Severe Shock and Resuscitationactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.146Neonatal Severe Respiratory Complicationsactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.147Neonatal Severe Respiratory Complicationsactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.148Neonatal Severe Respiratory Complicationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.149Neonatal Severe Infectionactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.150Neonatal Severe Infectionactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.151Neonatal Severe Infectionactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.152Neonatal Severe Neurological Complicationsactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.153Neonatal Severe Neurological Complicationsactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.154Neonatal Severe Neurological Complicationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.155Neonatal Severe Shock and Resuscitation Proceduresactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.156Neonatal Severe Shock and Resuscitation Proceduresactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.157Neonatal Severe Shock and Resuscitation Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.158Neonatal Severe Respiratory Proceduresactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.159Neonatal Severe Respiratory Proceduresactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.160Neonatal Severe Respiratory Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.161Neonatal Severe Neurological Proceduresactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.162Neonatal Severe Neurological Proceduresactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.163Neonatal Severe Neurological Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.164Neonatal Severe Septicemiaactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.165Neonatal Severe Septicemiaactive2024-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.166Neonatal Severe Septicemiaactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.167Neonatal Moderate Birth Traumaactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.168Neonatal Moderate Birth Traumaactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.169Neonatal Moderate Birth Traumaactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.170Neonatal Moderate Respiratory Complicationsactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.171Neonatal Moderate Respiratory Complicationsactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.172Neonatal Moderate Respiratory Complicationsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.173Neonatal Moderate Respiratory Complications Proceduresactive2021-06ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.174Neonatal Moderate Respiratory Complications Proceduresactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.175Neonatal Moderate Respiratory Complications Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.176Neonatal Moderate Birth Trauma with LOSactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.177Neonatal Moderate Birth Trauma with LOSactive2025-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.178Neonatal Moderate Birth Trauma with LOSactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.179Neonatal Moderate Respiratory Complications with LOSactive2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.180Neonatal Moderate Respiratory Complications with LOSactive2024-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.181Neonatal Moderate Respiratory Complications with LOSactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.182Moderate Neurological Complications with LOS Proceduresactive2019-01ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.183Neonatal Moderate Neurological Complications with LOS Proceduresactive2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1029.184Neonatal Moderate Neurological Complications with LOS Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.185Neonatal Moderate Respiratory complications with LOS Proceduresactive2024-05ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.186Neonatal Moderate Respiratory complications with LOS Proceduresactive2024-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.187Neonatal Moderate Respiratory complications with LOS Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.188Single Liveborn Newborn Vaginalactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.189Single Liveborn Newborn Vaginalactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.190Single Liveborn Newborn Vaginalactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.191Single Liveborn Newborn Cesareanactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.192Single Liveborn Newborn Cesareanactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.193Single Liveborn Newborn Cesareanactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.194Birth Weightactive2021-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1029.195Neonatal Moderate Infection with LOSactive2021-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.196Neonatal Moderate Infection with LOSactive2024-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.197Neonatal Moderate Infection with LOSactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.203Neonatal Intensive Care Unitactive2022-02ushl7cdc
us.nlm.vsacR42.16.840.1.113762.1.4.1029.204Intensive Care Unitactive2021-02ushl7cdc
us.nlm.vsacR42.16.840.1.113762.1.4.1029.205Neonatal Intensive Care Unitactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.206Intensive Care Unitactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.208Blood Transfusion Administrationactive2024-07ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.209Blood Transfusion Administrationactive2024-09ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.213Blood Transfusionactive2022-01ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.214Acute Respiratory Distress Syndromeactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.217Amniotic Fluid Embolismactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.219Aortic Aneurysmactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.220Aortic Aneurysmactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.221Cardiac Arrest Ventricular Fibrillationactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.223Disseminated Intravascular Coagulationactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.225Eclampsiaactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.227Heart Failure Cardiac Arrest Related to Procedure or Surgeryactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.228Heart Failure Cardiac Arrest Related to Procedure or Surgeryactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.229Puerperal Cerebrovascular Disorderactive2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.231Pulmonary Edemaactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.233Acute Heart Failureactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.235Severe Anesthesia Complicationsactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.237Sepsisactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.239Shockactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.24Blood Transfusion Administrationactive2024-09ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.241Sickle Cell Disease with Crisisactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.243Air and Thrombotic Embolismactive2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.245Blood Transfusionactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.246Blood Transfusionactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.247Conversion of Cardiac Rhythmactive2022-01ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.248Conversion of Cardiac Rhythmactive2021-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.249Hysterectomyactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.250Hysterectomyactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.251Tracheostomyactive2022-01ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.252Tracheostomyactive2021-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.253Ventilationactive2022-01ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1029.254Ventilationactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1029.255Severe Maternal Morbidity Diagnosesactive2022-01ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.256Severe Maternal Morbidity Proceduresactive2023-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1029.267Gestational Diabetesactive2022-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1029.269Gestational Diabetesactive2022-01ushl7vsac